XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings per share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings per Share

The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2023 and 2022:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Calculation of basic and diluted loss per share
     attributable to the Company’s shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to the Company’s shareholders

 

$

(5,102,317

)

 

$

(7,076,068

)

 

$

(19,337,023

)

 

$

(10,866,209

)

Weighted-average common shares outstanding –
     basic and diluted

 

 

52,406,002

 

 

 

43,030,885

 

 

 

51,084,636

 

 

 

43,042,379

 

Net loss per share, basic and diluted

 

$

(0.10

)

 

$

(0.16

)

 

$

(0.38

)

 

$

(0.25

)

Summary of Anti-dilutive Shares Excluded from Calculation of Diluted Net Loss per Share The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Stock options and awards

 

 

704,231

 

 

 

1,004,845

 

 

 

652,111

 

 

 

2,181,361

 

Convertible Debt

 

 

389,904

 

 

 

 

 

 

389,904

 

 

 

 

Common Stock Warrants (1)

 

 

13,832,890

 

 

 

5,958,600

 

 

 

13,832,890

 

 

 

5,958,600

 

Earnout Shares (2)

 

 

10,491,937

 

 

 

10,491,937

 

 

 

10,491,937

 

 

 

10,491,937

 

Contingently issuable Earnout Shares from unexercised Rollover
   Options

 

 

1,508,063

 

 

 

1,508,063

 

 

 

1,508,063

 

 

 

1,508,063

 

Total

 

 

26,927,025

 

 

 

18,963,445

 

 

 

26,874,905

 

 

 

20,139,961

 

(1)
Included in Common Stock Warrants are the 5,750,000 publicly-traded warrants (the “Public Warrants”), 208,600 warrants held by assignees of Big Cypress Holdings, LLC (the “Private Placement Warrants”), 300,000 warrants held by Ladenburg Thalmann & Co. Inc. (the “Ladenburg Warrants”), 7,363,377 warrants issued to the investors in the December Private Placement (the “the PIPE Warrants”), and 210,913 warrants issued to the placement agent in the December Private Placement (the “PIPE Placement Agent Warrants”). See Note 12, Fair Value Measurements for further details on the Company’s outstanding warrants.
(2)
As the Earnout Shares are subject to certain vesting requirements not satisfied as of the three and nine months ended September 30, 2023 and 2022, the Earnout Shares held in escrow are excluded from calculating both basic and diluted earnings per share. See Note 10, Stockholders Equity for further details on the Company’s outstanding equity instruments.